 OUTLINE: This is a randomized, placebo-controlled, multicenter study. Patients are stratified according to invasiveness of disease non-invasive stage Ta, Tis, or T1 vs invasive stage T2, T3, or T4. Patients are randomized to 1 of 3 treatment arms. 